Privigen 10% vial 400ML
Ended Awarded
- Contract number
- SPE2DR26FDJC5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,945
Award facts
- Contract value 100% obligated
- $20,944.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,944.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of PRIVIGEN 10% Vial 400ML. This firm fixed-price delivery order, issued on November 7, 2025, with an ultimate completion date of December 2, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was funded by the DLA and executed under the company's existing Indefinite Delivery Contract (IDC) with the DLA.
This delivery order is issued under DMS Pharmaceutical Group's single-award IDC designated SPE2DR within the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. The parent contract, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. As a critical pharmaceutical supplier within the federal military medical supply chain, DMS Pharmaceutical Group has demonstrated substantial performance across multiple therapeutic categories, enabling it to fulfill the specialized and diverse pharmaceutical requirements of DoD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FDJC5?
SPE2DR26FDJC5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26FDJC5 worth?
The government has obligated $20,945 on SPE2DR26FDJC5.
Is contract SPE2DR26FDJC5 an order under another contract?
Yes. SPE2DR26FDJC5 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJC5 competed?
The extent of competition for SPE2DR26FDJC5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award